Rare diseases
Investigational molecules
Locations
Calle De San Carlos 4, 45001 Toledo, Spain
Sinfatin S.L. is engaged in clinical research focused on spinal cord injury, with attention to functional recovery after cervical spinal cord injury and the restoration of upper-limb performance.
The sponsor’s research activity in this area is centered on neurological impairment affecting hand use, including outcomes related to strength, dexterity, and coordinated grasping ability.
Sinfatin S.L. runs clinical trials in conditions such as Cerebrovascular accident, Post-acute COVID-19 syndrome, Spinal cord injury cervical, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Rimonabant for Improving Cognitive Impairment in Patients with Post‑COVID‑19 Syndrome: A Randomized, Placebo‑Controlled Trial
SpainRimonabant for Improving Walking Ability in Post‑Stroke Patients in the Chronic Phase
SpainEffect of Rimonabant on Functional Recovery in Subacute Stroke Patients
SpainAn exploratory study to evaluate the effect of rimonabant on hand function in patients with cervical spinal cord injury
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
